Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R.
Int J Mol Sci. 2021 May 29;22(11):5850. doi: 10.3390/ijms22115850.
The Diagnosis and Management of Neurofibromatosis Type 1.
Ly KI, Blakeley JO.
Med Clin North Am. 2019 Nov;103(6):1035-1054. doi: 10.1016/j.mcna.2019.07.004.
Neurofibromatoses.
Jordan JT, Plotkin SR.
Hematol Oncol Clin North Am. 2022 Feb;36(1):253-267. doi: 10.1016/j.hoc.2021.08.010. Epub 2021 Oct 27.
Diagnostic Pathology of Tumors of Peripheral Nerve.
Belakhoua SM, Rodriguez FJ.
Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021.
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R.
Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31.
Neurofibromatoses.
Uhlmann EJ, Plotkin SR.
Adv Exp Med Biol. 2012;724:266-77. doi: 10.1007/978-1-4614-0653-2_20.
Neurofibromatosis.
Korf BR.
Handb Clin Neurol. 2013;111:333-40. doi: 10.1016/B978-0-444-52891-9.00039-7.
Neurofibromatosis.
Adeghate J, Tsang S, Sharma T.
Adv Exp Med Biol. 2025;1467:235-237. doi: 10.1007/978-3-031-72230-1_46.
Neurofibromatosis and Schwannomatosis.
Plotkin SR, Wick A.
Semin Neurol. 2018 Feb;38(1):73-85. doi: 10.1055/s-0038-1627471. Epub 2018 Mar 16.
[Neurofibromatosis].
Wolkenstein P, Decq P.
Neurochirurgie. 1998 Nov;44(4):267-72.
